Przegląd Dermatologiczny
facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
4/2025
vol. 112
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł przeglądowy

Epidemiological Patterns in Tumor Transformation of Nevus Sebaceous: a Systematic Review

Fabiola L. Silva
1
,
Marina M. Burlá
2
,
Beatriz X. Mendes
3
,
Yuri S. Siqueira
4
,
Lilia Maria L. de Oliveira
5

  1. Division of Dermatology, Department of Medicine, Federal University of Bahia, Brazil
  2. Department of Medicine, Estácio de Sá Vista Carioca University, Rio de Janeiro, Brazil
  3. Department of Medicine, Unichristus University Center, Ceara, Brazil
  4. Department of Medicine, Universidade do Extremo Sul Catarinense, Criciuma, Brazil
  5. Harvard T.H. Chan School of Public Health, Boston, US
Dermatol Rev/Przegl Dermatol 2025, 112, 243–248
Data publikacji online: 2025/10/30
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Nevus sebaceous is a congenital hamartoma with potential for secondary tumor development. This systematic review, registered in PROSPERO (CRD42024533102), presents the largest epidemiologic analysis to date, encompassing 7,092 nevus sebaceous cases across 27 observational studies. Secondary tumors were identified in 12% of cases – 10% benign and 2% malignant. Syringocystadenoma papilliferum and trichoblastoma were the most frequent benign neoplasms, while basal cell carcinoma accounted for the majority of malignancies. Multiple neoplasms within a single lesion were rare (1%), and tumor development was more common in adult males. While benign tumors are relatively common, malignant transformation remains rare. These findings challenge the practice of routine prophylactic excision, particularly in pediatric patients, and support a more individualized approach based on clinical risk assessment and lesion characteristics.


© 2025 Termedia Sp. z o.o.
Developed by Bentus.